Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02745392 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
A Phase 2 study of Acute Migraine, sponsored by Zosano Pharma Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 365
- Enrollment target
- 20
- Study locations
NCT02745392 is a Phase 2 study of Acute Migraine that has completed, run by Zosano Pharma Corporation. The registered enrollment target is 365 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT02745392, a Phase 2 study of Acute Migraine, has completed, sponsored by Zosano Pharma Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 365 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a randomized, double-blind, multi-center, parallel-group study designed to compare the safety and efficacy of a range of doses of ZP-Zolmitriptan intracutaneous microneedle systems to placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG ZP-Zolmitriptan
Study Locations (20)
California
- The Research Center of Southern California - Carlsbad
- Allergy and Asthma Specialists Medical Group and Research Center - Huntington Beach
- Downtown LA Research Center - Los Angeles
- Allergy & Asthma Associates of Southern California - Mission Viejo
- Allergy and Asthma Associates of Santa Clara Valley Research Center - San Jose
- California Medical Clinic for Headache - Santa Monica
- Empire Clinical Research - Upland
Massachusetts
- Boston Clinical Trials - Boston
- Novex Medical Research - New Bedford
- Northeast Medical Research Associates, Inc. - North Dartmouth
- MedVadis Research Corporation - Watertown
Florida
- Avail Clinical Research, LLC - DeLand
- Medical Research Group of Central Florida - Orange City
- Meridien Research - Tampa
Michigan
- Michigan Head Pain &Neurological Institute - Ann Arbor
- Westside Family Medical Center, P.C - Kalamazoo
Arizona
- Clinical Research Advantage, Inc./Thunderbird Internal Medicine - Glendale
Colorado
- Colorado Allergy & AsthmaCenters, PC - Denver
Connecticut
- Ki Health Partners - Stamford
Georgia
- Clinical Research Atlanta - Stockbridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02745392
The ClinicalTrials.gov registry entry for NCT02745392 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 365 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zosano Pharma Corporation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Migraine appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02745392 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Massachusetts, Florida.
Frequently Asked Questions
What is clinical trial NCT02745392 about?
NCT02745392 is a clinical study titled "Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine". This is a randomized, double-blind, multi-center, parallel-group study designed to compare the safety and efficacy of a range of doses of ZP-Zolmitriptan intracutaneous microneedle systems to placebo.
What is the current status of trial NCT02745392?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 365 participants. The study started on 2016-06. Estimated completion is 2017-01.
What conditions does trial NCT02745392 study?
This clinical trial studies the following conditions: Acute Migraine.
What interventions are being tested in trial NCT02745392?
The interventions under investigation include: Placebo (DRUG), ZP-Zolmitriptan (DRUG).
Who is sponsoring clinical trial NCT02745392?
This trial is sponsored by Zosano Pharma Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02745392 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.